Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CXCR2/IL-8RB Antibody (MM0222-7J40) - Azide and BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP212413
Description
CXCR2/IL-8RB Monoclonal specifically detects CXCR2/IL-8RB in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, CyTOF-ready, Block/Neutralize.Specifications
CXCR2/IL-8RB | |
Monoclonal | |
LYOPH | |
Western Blot 1:500-1:1000, Flow Cytometry 1:50-200, Immunohistochemistry 1:10-1:500, Immunohistochemistry-Paraffin 1:50-1:100, Immunohistochemistry-Frozen 1:50-1:100, CyTOF-ready, Block/Neutralize | |
AAB25880 | |
CXCR2 | |
Human recombinant CXCR2/IL-8RB | |
0.1 mg | |
Angiogenesis, Cancer, Cytokine Research, GPCR, Immunology, Innate Immunity | |
3579 | |
Human | |
Purified |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), CyTOF, Neutralization | |
MM0222-7J40 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS. 0.025 mg size is provided in liquid form, PBS with No Preservative | |
CD182 antigen, CDw128b, chemokine (C-X-C motif) receptor 2, chemokine (CXC) receptor 2, C-X-C chemokine receptor type 2, CXC-R2, CXCR-2, CXCR2 gene for IL8 receptor type B, GRO/MGSA receptor, High affinity interleukin-8 receptor B, IL-8 receptor type 2, IL-8R B, IL8R2, IL8RA, interleukin 8 receptor B, interleukin 8 receptor type 2, interleukin-8 receptor type B | |
Mouse | |
Protein G purified | |
RUO | |
Primary | |
Reconstitute with sterilized PBS to a final concentration of 0.5 mg/ml. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG2 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction